Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Active Shortage

APO-OLMESARTAN/HCTZ

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-OLMESARTAN/HCTZ in Canada?

Yes. APO-OLMESARTAN/HCTZ 12.5MG 40MG has an active shortage reported to Health Canada (last updated November 14, 2024).

Why is APO-OLMESARTAN/HCTZ not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-OLMESARTAN/HCTZ be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist
StatusActive Shortage
Same-ingredient products on fileNone found
Affected strength12.5MG 40MG
Report last updated2024-11-14
Checked by MedShort2026-11-12

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02453614

Strength

12.5MG 40MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL

Tier

Unrated

Last Updated

2024-11-14

Reason for Shortage

Disruption of the manufacture of the drug.